Therefore, the association between the reported CD47 expression and adverse pathological features (including advanced TNM stage, lymphovascular invasion and tumor budding) should be interpreted with caution [107], as the current evidence only indicates a correlation rather than a causal relationship. The gene discussed is CD47; the disease is neoplasm.